Matthew C Kapusta's Net Worth
$28.9 Million
Who is Matthew C Kapusta?
Matthew C Kapusta has an estimated net worth of $28.9 Million. This is based on reported shares across multiple companies, which include ANGIODYNAMICS INC, uniQure N.V., and Decibel Therapeutics, Inc..
SEC CIK
Matthew C Kapusta's CIK is 0001536290
Past Insider Trading and Trends
2020 was Matthew C Kapusta's most active year for acquiring shares with 9 total transactions. Matthew C Kapusta's most active month to acquire stocks was the month of January. 2020 was Matthew C Kapusta's most active year for disposing of shares, totalling 50 transactions. Matthew C Kapusta's most active month to dispose stocks was the month of December. 2020 saw Matthew C Kapusta paying a total of $254,845.32 for 160,250 shares, this is the most they've acquired in one year. In 2019 Matthew C Kapusta cashed out on 150,001 shares for a total of $8,701,773.33, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ANGIODYNAMICS INC (ANGO) Snapshot price: $7.2
SVP, Business DevelopmentMatthew C Kapusta owns 30,062 units of Common Stock which is worth $216,446.40. In the year 2011 Matthew C Kapusta acquired a total of 32,243 shares in ANGIODYNAMICS INC at a cost of $25,297.00, Matthew also disposed a total of 5,778 shares of ANGIODYNAMICS INC equalling to $81,604.10.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -4.43% | -1.39K |
$16.85 | -$23,455.20 | 30.06K |
Nov 17
| |||
Form 4
| -3.48% | -1.11K |
$14.72 | -$16,281.70 | 30.7K |
Aug 3 - Aug 6
| |||
Form 4
| +17.79% | 4.8K |
—
|
—
| 31.81K |
Jul 25
| |||
Form 4
| +3.85% | 1K |
$13.90 | $13,900.00 | 27K |
Apr 14
| |||
Form 4
| -5.67% | -1.39K |
$15.62 | -$21,743.04 | 23.16K |
Nov 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 1
| |||
Form 4
| +28.45% | 5.44K |
—
|
—
| 24.55K |
Aug 6
| |||
Form 4
| -2.70% | -530.00 |
$12.04 | -$6,381.20 | 19.11K |
Aug 3
| |||
Form 4
| -6.47% | -1.36K |
$10.12 | -$13,742.96 | 19.64K |
Nov 15
| |||
Form 4
| +31.25% | 5K |
—
|
—
| 21K |
Aug 17
| |||
Form 4
| +6.67% | 1K |
$11.40 | $11,397.00 | 16K |
Apr 10
| |||
Form 4
|
∞
| 15K |
—
|
—
| 15K |
Feb 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
uniQure N.V. (QURE) Snapshot price: $5.42
CEO, Managing DirectorMatthew C Kapusta owns 590,839 units of Ordinary Shares which is worth $3,202,347.38. From 2017 to 2024 Matthew C Kapusta acquired a total of 947,384 shares in uniQure N.V. at a cost of $310,107.99, Matthew also disposed a total of 587,108 shares of uniQure N.V. equalling to $25,751,617.74.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +34.03% | 150K |
—
|
—
| 590.84K |
Mar 1
| |||
Form 4
| -5.95% | -27.90K |
$6.35 | -$177,190.40 | 440.84K |
Feb 26
| |||
Form 4
| -0.53% | -2.52K |
$21.39 | -$53,924.19 | 468.74K |
Mar 7
| |||
Form 4
| -4.95% | -24.55K |
$20.09 | -$493,251.56 | 471.26K |
Feb 27 - Feb 28
| |||
Form 4
| +32.46% | 121.5K |
—
|
—
| 495.81K |
Feb 23
| |||
Form 4
| +1.58% | 5.83K |
—
|
—
| 374.31K |
Feb 20
| |||
Form 4
| -1.77% | -6.65K |
$22.44 | -$149,181.12 | 368.48K |
Dec 9
| |||
Form 4
| +4.04% | 14.57K |
—
|
—
| 375.13K |
Nov 22
| |||
Form 4
| -2.75% | -10.20K |
$16.70 | -$170,256.50 | 360.55K |
Feb 28
| |||
Form 4
| +50.91% | 125.07K |
—
|
—
| 370.75K |
Feb 24
| |||
Form 4
| -4.25% | -10.90K |
$18.10 | -$197,308.10 | 245.68K |
Jan 26
| |||
Form 4
| -0.39% | -1.00K |
$28.15 | -$28,145.52 | 256.58K |
Scheduled
|
Aug 18
| ||
Form 4
| -0.39% | -1.00K |
$27.77 | -$27,770.00 | 257.58K |
Scheduled
|
Jul 14
| ||
Form 4
| -2.03% | -5.35K |
$34.76 | -$185,952.59 | 258.58K |
Scheduled
|
Jun 16 - Jun 17
| ||
Form 4
| -0.85% | -2.25K |
$32.29 | -$72,652.50 | 263.93K |
Scheduled
|
May 12
| ||
Form 4
| -1.97% | -5.35K |
$35.24 | -$188,517.86 | 266.18K |
Scheduled
|
Apr 14
| ||
Form 4
| -0.82% | -2.25K |
$33.16 | -$74,616.72 | 271.53K |
Scheduled
|
Mar 17
| ||
Form 4
| -1.78% | -4.97K |
$36.94 | -$183,739.56 | 273.78K |
Mar 2
| |||
Form 4
| +25.04% | 55.81K |
—
|
—
| 278.75K |
Feb 25
| |||
Form 4
| -1.68% | -3.80K |
$35.38 | -$134,451.50 | 222.94K |
Scheduled
|
Feb 15
| ||
Form 4
| -2.99% | -7.00K |
$35.58 | -$249,048.80 | 226.74K |
Scheduled
|
Jan 29
| ||
Form 4
| -11.88% | -31.50K |
$36.63 | -$1,153,786.03 | 233.74K |
Jan 27 - Jan 28
| |||
Form 4
| -11.88% | -31.50K |
$36.63 | -$1,153,786.03 | 233.74K |
Jan 27 - Jan 28
| |||
Form 4
|
—
|
0
|
$27.97 | -$511,040.95 | 265.24K |
Scheduled
|
Dec 16
| ||
Form 4
| -3.01% | -8.23K |
$26.36 | -$489,487.65 | 265.24K |
Scheduled
|
Nov 19
| ||
Form 4
| -2.53% | -7.10K |
$25.61 | -$426,362.07 | 273.47K |
Scheduled
|
Nov 18
| ||
Form 4
| -1.84% | -5.25K |
$35.86 | -$188,256.00 | 280.56K |
Scheduled
|
Oct 14
| ||
Form 4
| -2.56% | -7.50K |
$40.66 | -$304,939.13 | 285.81K |
Scheduled
|
Sep 16
| ||
Form 4
| -0.10% | -300.00 |
$40.27 | -$12,081.00 | 293.31K |
Scheduled
|
Aug 25
| ||
Form 4
| -1.44% | -4.30K |
$39.11 | -$168,175.00 | 293.61K |
Scheduled
|
Aug 19
| ||
Form 4
| -1.85% | -5.63K |
$42.31 | -$238,024.63 | 297.91K |
Scheduled
|
Jul 22
| ||
Form 4
| -2.41% | -7.50K |
$66.04 | -$495,366.28 | 303.54K |
Scheduled
|
Jun 17
| ||
Form 4
| -2.35% | -7.50K |
$59.94 | -$449,579.88 | 311.04K |
Scheduled
|
May 20
| ||
Form 4
|
—
|
0
|
$32.20 | -$462,603.52 | 318.54K |
Scheduled
|
Apr 22
| ||
Form 4
|
—
|
0
|
$24.51 | -$190,988.58 | 318.54K |
Scheduled
|
Mar 18
| ||
Form 4
| +11.87% | 33.79K |
—
|
—
| 318.54K |
Feb 27
| |||
Form 4
| -2.57% | -7.50K |
$64.56 | -$484,256.06 | 284.75K |
Scheduled
|
Feb 19
| ||
Form 4
| +10.48% | 27.71K |
—
|
—
| 292.25K |
Jan 31
| |||
Form 4
| -16.17% | -51.04K |
$60.42 | -$3,083,938.41 | 264.54K |
Scheduled
|
Jan 29 - Jan 31
| ||
Form 4
| -14.12% | -51.87K |
$63.90 | -$3,314,501.04 | 315.58K |
Scheduled
|
Jan 27 - Jan 28
| ||
Form 4
| -0.05% | -201.00 |
$38.81 | -$473,247.79 | 367.45K |
Scheduled
|
Dec 18
| ||
Form 4
| -2.13% | -8.00K |
$53.74 | -$429,951.00 | 367.65K |
Scheduled
|
Nov 20
| ||
Form 4
| -2.09% | -8.00K |
$43.22 | -$345,780.64 | 375.65K |
Scheduled
|
Oct 23
| ||
Form 4
| -2.04% | -8.00K |
$47.31 | -$378,485.58 | 383.65K |
Scheduled
|
Sep 18
| ||
Form 4
| -2.00% | -8.00K |
$56.48 | -$451,840.00 | 391.23K |
Scheduled
|
Aug 21
| ||
Form 4
| -1.96% | -8.00K |
$71.45 | -$571,615.82 | 399.23K |
Scheduled
|
Jul 17
| ||
Form 4
| -1.93% | -8.00K |
$77.45 | -$619,625.67 | 407.23K |
Scheduled
|
Jun 19
| ||
Form 4
| -1.89% | -8.00K |
$58.38 | -$467,016.66 | 415.23K |
Scheduled
|
May 15
| ||
Form 4
| -13.73% | -67.38K |
$63.96 | -$4,309,296.80 | 423.23K |
Scheduled
|
Mar 13 - Mar 14
| ||
Form 4
| -3.75% | -19.09K |
$31.42 | -$599,650.70 | 490.03K |
Scheduled
|
Jan 28
| ||
Form 4
| +15.77% | 69.35K |
—
|
—
| 509.11K |
Jan 25
| |||
Form 4
| -8.18% | -39.17K |
$21.72 | -$850,750.68 | 439.76K |
Mar 15
| |||
Form 4
| +7.01% | 31.37K |
—
|
—
| 478.93K |
Jan 26
| |||
Form 4
| -4.62% | -21.69K |
$19.87 | -$431,069.23 | 447.56K |
Jan 4
| |||
Form 4
|
∞
| 271.19K |
—
|
—
| 271.19K |
Dec 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Decibel Therapeutics, Inc. No price found
InvestorMatthew C Kapusta used to own units in Common Stock but no longer holds any shares there. In the year 2023 Matthew C Kapusta filed a total of 3 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -10.00K |
—
|
—
|
0
|
Sep 25
| |||
Form 4
|
∞
| 10K |
—
|
—
| 10K |
Mar 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |